Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report
Pre-publication versions of this article are available by contacting email@example.com.
|27 Mar 2018||Submitted||Original manuscript|
|26 Jul 2018||Reviewed||Reviewer Report - Bin Wu|
|4 Sep 2018||Reviewed||Reviewer Report - Torsten Liersch|
|4 Sep 2018||Reviewed||Reviewer Report - Reviewer 2|
|19 Sep 2018||Author responded||Author comments - Zhenyu Lin|
|Resubmission - Version 2|
|19 Sep 2018||Submitted||Manuscript version 2|
|8 Oct 2018||Reviewed||Reviewer Report - Torsten Liersch|
|12 Oct 2018||Reviewed||Reviewer Report - Bin Wu|
|18 Oct 2018||Reviewed||Reviewer Report - Reviewer 2|
|23 Oct 2018||Author responded||Author comments - Zhenyu Lin|
|Resubmission - Version 3|
|23 Oct 2018||Submitted||Manuscript version 3|
|4 Dec 2018||Editorially accepted|
|14 Dec 2018||Article published||10.1186/s12885-018-5182-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.